Format

Send to

Choose Destination
See comment in PubMed Commons below
Basic Res Cardiol. 2008 Mar;103(2):105-13. doi: 10.1007/s00395-008-0704-5.

Imaging of stem cells using MRI.

Author information

1
Russell H. Morgan Dept. of Radiology and Radiological Science, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. dara@mri.jhu.edu

Abstract

The administration of exogenous stem cells offers promise to regenerate many damaged organs. However, failures of these cellular therapies could be related to many issues, such as the type of stem cell, the dose of cellular therapeutic, dosing regime, and mode of delivery. The recent ability to directly label stem cells with magnetic resonance (MR) contrast agents provides a simple, straight-forward manner to monitor accurate cell delivery and track stem cells non-invasively in a serial manner. Provided here is an overview of the currently available MR-labeling methods, including direct non-specific labeling with contrast agents, indirect specific labeling with contrast agents, labeling with MRI reporter genes, and fluorine hot spot labeling. Several of these approaches have now been applied successfully in preclinical animal models of cardiovascular disease. Once properly implemented, future clinical trials may benefit greatly from imaging stem cells with MRI.

PMID:
18324366
PMCID:
PMC3037795
DOI:
10.1007/s00395-008-0704-5
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center